CR Group L.P. - 25 Sep 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
10%+ Owner
Signature
/s/ Nathan D. Hukill, authorized signatory for CRG Partners III L.P., CRG Partners III Parallel Fund (A) L.P., CRG Partners III (Cayman) Unlev AIV I L.P., and CRG Partners III (Cayman) Lev AIV I L.P.
Issuer symbol
TTOO
Transactions as of
25 Sep 2023
Net transactions value
-$62,500
Form type
4
Filing time
27 Sep 2023, 17:53:55 UTC
Previous filing
26 Sep 2023
Next filing
28 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Sale $24,995 -99,979 -1.3% $0.2500 7,407,678 25 Sep 2023 By CRG Partners III L.P. F1
transaction TTOO Common Stock Sale $15,564 -62,258 -1.3% $0.2500 4,612,840 25 Sep 2023 By CRG Partners III ? Parallel Fund ?A? L.P. F1
transaction TTOO Common Stock Sale $4,999 -19,996 -1.3% $0.2500 1,481,535 25 Sep 2023 By CRG Partners III (Cayman) Unlev AIV I L.P. F1
transaction TTOO Common Stock Sale $16,942 -67,767 -1.3% $0.2500 5,021,014 25 Sep 2023 By CRG Partners III (Cayman) Lev AIV I L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.